Evidence map›Paper›PMID 33853838›Full record

ArticleJournal of clinical microbiology2021

Mycoplasma pneumoniae Genotypes and Clinical Outcome in Children.

Patrick M Meyer Sauteur, Elena Pánisová, Michelle Seiler, Martin Theiler, Christoph Berger, Roger Dumke

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Open forum infectious diseases · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. JAC-antimicrobial resistance · 2025
    Article
  7. Genetic factors driving theThe Lancet regional health. Western Pacific · 2025
    Article
  8. Understanding the unconventional reemergence ofTranslational pediatrics · 2025
    Review
  9. Article
  10. Article
  11. Advances in adhesion-related pathogenesis inFrontiers in microbiology · 2025
    Review
  12. P1 adhesin genotype characteristics ofFrontiers in cellular and infection microbiology · 2025
    Article
  13. Article
  14. Macrolide-resistantHeliyon · 2024
    Article
  15. Increased macrolide resistance rate ofFrontiers in microbiology · 2024
    Article
  16. Review
  17. The Association betweenMicroorganisms · 2023
    Article
  18. Review
  19. Article
  20. Molecular Tools for TypingFrontiers in microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Patrick M Meyer SauteurDivision of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, Zurich, Switzerland.
Elena PánisováDivision of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, Zurich, Switzerland.
Michelle SeilerEmergency Department, University Children's Hospital Zurich, Zurich, Switzerland.
Martin TheilerPediatric Skin Center, Department of Dermatology, University Children's Hospital Zurich, Zurich, Switzerland.
Christoph Berger *Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, Zurich, Switzerland.
Roger Dumke *TU Dresden, Medical Faculty Carl Gustav Carus, Institute of Medical Microbiology and Hygiene, Dresden, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Factors leading to the wide range of manifestations associated with Mycoplasma pneumoniae infection are unclear. We investigated whether M. pneumoniae genotypes are associated with specific clinical outcomes. We compared M. pneumoniae loads and genotypes of children with mucocutaneous disease to those of children with pneumonia, family members with upper respiratory tract infection (URTI), and carriers from a prospective cohort study (

Indexed as

Mycoplasma pneumoniaePneumonia, MycoplasmaAnti-Bacterial AgentsChildDrug Resistance, BacterialGenotypeHumansMacrolidesMultilocus Sequence TypingProspective StudiesAnti-Bacterial AgentsMacrolidesantimicrobial resistance (AMR)community-acquired pneumonia (CAP)multilocus variable-number tandem-repeat analysis (MLVA)Mycoplasma pneumoniae-induced rash and mucositis (MIRM)whole-genome sequencing (WGS)

Identifiers

PMID33853838
PMCPMC8373298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.